Article: The Botanical Science Behind Targeted Comfort: Why Midori Relief Crème Is Built Different

The Botanical Science Behind Targeted Comfort: Why Midori Relief Crème Is Built Different
There's a reason people reach for the same topical formulas year after year for stiff joints, overworked muscles, and areas of persistent tension: the right combination of botanical actives, applied directly to the site, works in a way that nothing systemic can replicate. There's no waiting for absorption through the digestive tract, no systemic burden — just concentrated botanical activity delivered precisely where the body needs it.
Midori CBD + CBG Relief Crème was built around this principle. With 1,800mg CBD and 1,200mg CBG — 3,000mg total cannabinoids — alongside a curated warming botanical complex featuring turmeric, black pepper, ginger, arnica, eucalyptus, and peppermint, this formula brings together some of the most deeply studied plant compounds in comfort science. Available in both a 150mL airless pump and a 100mL airless pump, it's designed for people who take targeted body care seriously.
This is the research behind the formula.
Why Targeted Topical Application Matters
When botanicals are applied topically rather than ingested, they bypass the digestive and metabolic processes that can reduce their concentration before reaching their destination. The skin has its own endocannabinoid receptors, its own inflammatory signaling pathways, and its own capacity to absorb and respond to botanical actives — and topical delivery puts those actives in direct contact with the tissues and receptors at the surface.
For areas of persistent tension, stiffness, or daily physical wear, this makes a meaningful difference. Arthritis Australia's clinical overview notes that many people find topical CBD formulations provide their best results precisely because of this — direct delivery to the site of concern, without the absorption losses associated with oral routes. The Arthritis Foundation similarly notes that topical products are applied directly over a target joint or area, and anecdotal reports from arthritis patients consistently highlight topical CBD as a preferred format.
CBD (1,800mg): The Endocannabinoid Foundation
CBD (cannabidiol) is the primary cannabinoid in this formula — and its relationship with comfort and inflammatory pathways is one of the most researched areas in phytocannabinoid science.
The skin contains a network of CB1 and CB2 receptors as part of the body's endocannabinoid system (ECS). CB2 receptors in particular are closely associated with immune regulation and the inflammatory response. A comprehensive review published in the Journal of Cannabis Research (2022) analyzed CBD specifically in the context of arthritis and joint-related concerns, concluding that CBD has demonstrated pain-relieving and anti-inflammatory properties in both animal studies and small human trials. Harvard Health's review references one of the largest systematic reviews on cannabis and CBD which concluded there is "substantial evidence that cannabis is an effective treatment for chronic pain in adults."
A systematic review cited by Arthritis Australia found that 15 of 18 trials demonstrated a significant analgesic effect for CBD compared to placebo, with patients reporting over 30% reduction in pain intensity. CBD is also increasingly recognized for its favorable safety profile relative to conventional options — no gastrointestinal burden, no dependency concerns, and no systemic side effects associated with long-term NSAID use.
At 1,800mg in a single 150mL bottle, the CBD concentration in Midori Relief Crème is meaningfully elevated — designed for people who use targeted topicals regularly and understand that dose matters.
CBG (1,200mg): The Anti-Inflammatory Amplifier
CBG (cannabigerol) is the most scientifically exciting addition to this formula — a minor cannabinoid that is rapidly accumulating a significant body of research around its distinct anti-inflammatory mechanisms.
Unlike CBD, which primarily interacts with the ECS indirectly, CBG binds directly to both CB1 and CB2 receptors, as well as TRPV1 receptors involved in regulating pain signaling and temperature. A comprehensive review published in Molecules (PMC) (2024) documents CBG's capacity to modulate pro-inflammatory proteins by activating both cannabinoid receptor subtypes, reduce nitric oxide production in macrophages, diminish reactive oxygen species (ROS) formation, and inhibit COX-1 and COX-2 enzymes — the same enzymes targeted by NSAIDs, without the associated gastric risks.
Research on CBD and CBG in combination published in the British Journal of Pharmacology confirms that both cannabinoids exhibit anti-inflammatory and antioxidant properties individually, and that their combination produces complementary effects — CBD addressing anxiolytic and systemic inflammatory signaling while CBG adds direct receptor modulation and potent antioxidant activity that surpasses even Vitamin C in reducing reactive oxygen species in human dermal fibroblasts.
The 1,200mg of CBG in Midori Relief Crème is one of the highest CBG concentrations available in any commercial topical formula — a formulation decision that reflects the emerging science around CBG's unique value in a targeted comfort context.
Turmeric + Black Pepper: The Most Studied Botanical Pairing in Comfort Science
Turmeric (Curcuma longa) has been used in traditional medicine for over 4,000 years — and modern science has spent decades documenting the mechanisms behind that tradition.
The primary bioactive compound in turmeric is curcumin, a polyphenol that has been shown to modulate inflammatory signaling at multiple points simultaneously. Research published in the Journal of Veterinary Science confirmed that topically applied curcumin reduces the expression of COX-2 and NF-κB — two major pro-inflammatory pathways — directly in treated tissue. The same research notes a key advantage of topical delivery: "because most inflammatory diseases develop locally and near the surface of the body, topical application of curcumin to the site of inflammation offers the advantage of delivering the drug directly to the site of disease."
This is precisely the logic behind the topical route in Midori Relief Crème. Oral curcumin faces significant bioavailability challenges — extensive first-pass metabolism and low systemic absorption mean that most ingested curcumin never reaches target tissues. Applied topically, curcumin bypasses those limitations and delivers its COX-2 and NF-κB inhibiting activity directly where it's needed.
Black pepper extract (piperine) is paired with turmeric in this formula as a deliberate formulation choice. Piperine's role in enhancing the activity and presence of curcuminoids within a formula has been extensively studied and recognized in botanical medicine. Research published in the Journal of Experimental Pharmacology (2024) specifically investigates the bioavailability dynamics of curcumin and piperine together. The intentional pairing of turmeric and black pepper in Midori's formula reflects the same synergistic principle that has made this combination a cornerstone of botanical comfort formulation — curcumin delivers the anti-inflammatory activity, and piperine supports its presence within the formula.
This is the kind of considered ingredient work that separates a formulated product from a blended one.
Ginger: Ancient Remedy, Modern Research
Ginger (Zingiber officinale) has been used medicinally for thousands of years across Asian, Middle Eastern, and Western herbal traditions. Its reputation as a comfort botanical is backed by a substantial body of contemporary science.
The primary bioactive compounds in ginger — gingerols, shogaols, and zingerone — inhibit the COX-2 and LOX inflammatory pathways, comparable in mechanism to NSAIDs but without the gastric burden associated with long-term NSAID use. A comprehensive review published in Molecules by PMC (2022) concludes that ginger's bioactive compounds show "promising results in both human and animal models, reducing some of the main symptoms of rheumatoid arthritis," and that multiple clinical trials have confirmed ginger's analgesic and anti-inflammatory activity.
The review specifically notes that 6-shogaol reduced paw thickness and improved walking performance in an arthritic animal model, and that 8-shogaol showed significant inhibitory effect against TNF-α and IL-1β — two primary inflammatory cytokines implicated in joint-related inflammation. Anti-inflammatory effects of ginger essential oils in experimental rheumatoid arthritis models further found that crude ginger extracts combining both gingerols and essential oils were even more potent at inhibiting joint swelling than gingerols alone.
Ginger's gingerols also contribute to the warming, grounding sensation that defines Relief Crème's contact experience — a purposeful heat that signals activity at the surface and grounds the senses.
Arnica Montana: From Traditional Remedy to Clinical Evidence
Arnica (Arnica montana) is one of the most widely used botanical actives in topical comfort formulations — and one of the most clinically studied.
Its active compounds — sesquiterpene lactones, particularly helenalin — have been shown to inhibit NF-κB, the same key pro-inflammatory transcription factor targeted by turmeric's curcumin. Research reviewed by Physical Therapy First highlights a study of 204 patients with osteoarthritis of the interphalangeal joints in which topical arnica application three times daily showed similar effectiveness to ibuprofen in reducing pain, functional hand capacity, number of painful joints, and morning stiffness — a significant finding for a botanical topical.
Renn Wellness's clinical overview cites a study in the Journal of Biological Chemistry confirming arnica's ability to selectively inhibit NF-κB pathway activation, as well as a study in the Journal of Alternative and Complementary Medicine demonstrating arnica's effectiveness at alleviating discomfort and reducing the appearance of inflammation post-surgically. The conclusion from the literature: arnica is a potential therapeutic alternative to NSAIDs for targeted topical application, particularly in people managing concurrent medications.
In Midori Relief Crème, arnica works in concert with CBD, CBG, and turmeric's curcumin — three separate botanical mechanisms all targeting overlapping inflammatory pathways simultaneously.
Eucalyptus & Peppermint: The Cooling Botanical Complex
The eucalyptus and peppermint in this formula aren't just aromatic. They represent a distinct and well-documented botanical mechanism.
Eucalyptus oil contains 1,8-cineole (eucalyptol) as its primary active compound. Research published in Inflammopharmacology (2024) confirms that eucalyptus essential oils possess anti-inflammatory properties that make them valuable for addressing inflammatory conditions including arthritis — with topical and massage-based applications specifically noted for their ability to mitigate discomfort associated with rheumatism, sprains, and muscle tension. Healthline's clinical overview further notes eucalyptus oil's history of incorporation into topical formulations for pain relief specifically because of eucalyptol's documented anti-inflammatory activity.
Menthol — the primary active compound in peppermint oil — operates through a distinct and well-established analgesic mechanism. Research published in Frontiers in Molecular Neuroscience (2022) identifies menthol as activating TRPM8 receptors — cold-sensitive ion channels in the skin — which produce the signature cooling sensation and, through this receptor activation, reduce pain signals across multiple models of acute and inflammatory discomfort. A parallel study published in Pain (PMC) confirmed that TRPM8 serves as the primary mediator of menthol-induced analgesia, with L-menthol effectively reducing pain behaviors across all examined models of acute and inflammatory pain.
The combination of eucalyptus and peppermint in Relief Crème creates a layered cooling experience that is immediately noticeable on contact — and mechanistically meaningful, not just sensory.
The Synergy Principle: Why Every Ingredient Has a Role
What makes Midori Relief Crème genuinely different from standard topical formulas is the deliberate layering of botanical mechanisms — each ingredient targeting inflammatory and comfort pathways from a different angle simultaneously:
No single compound here does the full job. That's precisely the point — and it's what separates a thoughtfully formulated product from a bottle of single-ingredient extract in a lotion base.
Available in Two Sizes
Midori CBD + CBG Relief Crème is available in a 150mL airless pump (3,000mg total cannabinoids) for regular daily use and a 100mL airless pump (2,000mg total cannabinoids) for targeted or on-the-go use. Both formats deliver the same full botanical complex in a fast-absorbing, non-greasy formula engineered for precise, mess-free application.
The airless pump format preserves formula integrity — no contamination, no oxidation, no waste — and allows controlled, hygienic dispensing directly to the target area.
How to Use
Dispense 1–2 pumps directly onto the area of concern. Massage in with firm, circular strokes until fully absorbed. Apply post-activity, during a targeted self-massage, or any time an area needs focused botanical attention. Reapply as needed. Avoid contact with eyes and sensitive areas.
For best results, use consistently as part of a daily routine. The botanical actives in this formula — particularly CBD, CBG, curcumin, and ginger — show compounding effects with regular use as the body's endocannabinoid and inflammatory systems respond to consistent botanical support.
Shop the 150mL Relief Crème →
Shop the 100mL Relief Crème →
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before use if you have a diagnosed medical condition.
Sources
-
Cannabidiol as a Treatment for Arthritis and Joint Pain — PMC / Journal of Cannabis Research
-
CBD for Arthritis Pain: What You Should Know — Arthritis Foundation
-
Efficacy of CBD for Chronic Pain & Joint Disease — Arthritis Australia
-
Cannabigerol (CBG): A Comprehensive Review — PMC / Molecules
-
Anti-Inflammatory Effects of Cannabigerol In Vitro and In Vivo — PMC / Cells
-
Therapeutic Effect of Topical Curcumin — PMC / Journal of Veterinary Science
-
Investigating Bioavailability of Curcumin and Piperine — PMC / Journal of Experimental Pharmacology
-
Effectiveness and Safety of Arnica Montana in Post-Surgical Settings — Physical Therapy First
-
Arnica Cream for Muscle Soreness and Joint Pain — Renn Wellness
-
Therapeutic Applications of Eucalyptus Essential Oils — PMC / Inflammopharmacology
-
The Distinctive Role of Menthol in Pain and Analgesia — Frontiers in Molecular Neuroscience
-
TRPM8 is the Principal Mediator of Menthol-Induced Analgesia — PMC / Pain
-
Clinical Trials, Potential Mechanisms, and Adverse Effects of Arnica — PMC / Medicines
Want to learn more? Take a look at our other blog posts.
The Science Behind Midori Repair Balm: Why Your Skin Deserves Better Than Basic Moisture.
Cannabinoids in Skincare : What CBD, CBG, CBN & CBDA Actually Do
Why the Best Sleep of Your Life Starts With What Happens After You Fall Asleep
The Gold Standard of Skincare Ingredients: Why Manuka Honey UMF 16+ Changes Everything
Japanese Skincare Ingredients: The Ancient Botanicals Behind Midori's Body Oil Ritual.
